Squarepoint Ops LLC Curis Inc Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $137,088 - $469,189	-193,082 Reduced 89.34%	23,036 $23,000
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $403,095 - $895,185	174,500 Added 419.29%	216,118 $514,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $37,322 - $67,850	8,387 Added 25.24%	41,618 $198,000
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $230,623 - $294,094	33,231 New	33,231 $260,000
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $325,639 - $711,161	-43,710 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $254,242 - $370,649	-28,957 Reduced 39.85%	43,710 $495,000
Q4 2020 Feb 16, 2021	SELL	$1.08 - $8.2 $199,962 - $1.52 Million	-185,150 Reduced 71.81%	72,667 $595,000
Q3 2020 Nov 16, 2020	BUY	$0.95 - $1.42 $202,762 - $303,076	213,434 Added 480.89%	257,817 $302,000
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.7 $27,961 - $75,451	44,383 New	44,383 $54,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.